J0870 Imetelstat - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Imetelstat

Brand Name:

Rytelo

Strength:

1mg

HCPCS:

J0870

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Enzyme Inhibitor

Minor Drug Class:

Telomerase

Oral (Y/N):

No

FDA Approval Year:

2024

FDA Discontinuation Year:

CMS Effective Date:

Dec. 17, 2024

CMS Discontinuation Date:

Status:

In Use